SECARE 📈 Swedencare publ AB - Overview
Exchange: ST • Country: Sweden • Currency: SEK • Type: Common Stock • ISIN: SE0015988167
SECARE: Nutritional Supplements, Treats, Grooming Products, Pet Supplements, Topical Products
Swedencare AB (publ) operates as a multifaceted animal healthcare company, focusing on the development, manufacturing, marketing, and distribution of a wide range of products catering to the needs of cats, dogs, and horses. With a presence in multiple regions including Sweden, the United Kingdom, the rest of Europe, North America, Asia, and other international markets, the company has established a diverse portfolio of brands. These include Healthy Breeds, which offers nutritional supplements, treats, and grooming products; Innovet, providing supplements and topical products for various therapeutic areas such as orthopedics, behavior, and dermatology; and Stratford Animal Health, which supports the veterinary community with specialized solutions.
The company's product lineup is further expanded by brands like NaturVet, VETCLASSICS, and NutriScience, which offer health supplements for pets. Additionally, Pet MD provides a range of products including supplements, vitamins, dental care items, ear cleaners, pilling agents, and topicals. VetWELL offers vet-formulated pet care products, emphasizing the company's commitment to providing high-quality, veterinarian-endorsed solutions. Specific products such as ProDen PlaqueOff powder, dental bones, and dental bites address pet oral health issues, while Rx Vitamins for Pets caters to the nutritional needs of pets under veterinary care.
Swedencare AB (publ) employs a distribution strategy that leverages partnerships with veterinarians, pet stores, and online platforms to reach its customer base effectively. Founded in 1993 and headquartered in Malmö, Sweden, the company has evolved into a significant player in the animal healthcare sector. With its web presence at https://www.swedencare.com, the company provides easy access to information about its products and services. Listed with the ISIN SE0015988167 as a common stock, Swedencare AB (publ) falls under the Biotechnology sub-industry, reflecting its focus on innovative healthcare solutions for animals.
Additional Sources for SECARE Stock
SECARE Stock Overview
Market Cap in USD | 774m |
Sector | Healthcare |
Industry | Drug Manufacturers - Specialty & Generic |
GiC Sub-Industry | Biotechnology |
IPO / Inception |
SECARE Stock Ratings
Growth 5y | 24.9% |
Fundamental | 16.3% |
Dividend | 58.6% |
Rel. Strength Industry | -719 |
Analysts | - |
Fair Price Momentum | 41.99 SEK |
Fair Price DCF | 55.09 SEK |
SECARE Dividends
Dividend Yield 12m | 0.49% |
Yield on Cost 5y | 1.20% |
Annual Growth 5y | 11.96% |
Payout Consistency | 100.0% |
SECARE Growth Ratios
Growth Correlation 3m | 84.2% |
Growth Correlation 12m | -79.4% |
Growth Correlation 5y | 6.3% |
CAGR 5y | 20.19% |
CAGR/Mean DD 5y | 0.49 |
Sharpe Ratio 12m | -0.53 |
Alpha | -43.44 |
Beta | 0.85 |
Volatility | 35.70% |
Current Volume | 95k |
Average Volume 20d | 144.4k |
As of December 22, 2024, the stock is trading at SEK 48.22 with a total of 95,023 shares traded.
Over the past week, the price has changed by -7.27%, over one month by +5.03%, over three months by +3.06% and over the past year by -24.57%.
Neither. Based on ValueRay Fundamental Analyses, Swedencare publ AB is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 16.25 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of SECARE as of December 2024 is 41.99. This means that SECARE is currently overvalued and has a potential downside of -12.92%.
Swedencare publ AB has no consensus analysts rating.
According to ValueRays Forecast Model, SECARE Swedencare publ AB will be worth about 46.1 in December 2025. The stock is currently trading at 48.22. This means that the stock has a potential downside of -4.5%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 58.7 | 21.7% |
Analysts Target Price | - | - |
ValueRay Target Price | 46.1 | -4.5% |